Coronary microvascular obstruction in acute myocardial infarction
Top Cited Papers
- 12 September 2015
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 37 (13), 1024-1033
- https://doi.org/10.1093/eurheartj/ehv484
Abstract
The success of a primary percutaneous intervention (PCI) in the setting of ST elevation myocardial infarction depends on the functional and structural integrity of coronary microcirculation. Coronary microvascular dysfunction and obstruction (CMVO) occurs in up to half of patients submitted to apparently successful primary PCI and is associated to a much worse outcome. The current review summarizes the complex mechanisms responsible for CMVO, including pre-existing coronary microvascular dysfunction, and highlights the current limitations in the assessment of microvascular function. More importantly, at the light of the substantial failure of trials hitherto published on the treatment of CMVO, this review proposes a novel integrated therapeutic approach, which should overcome the limitations of previous studies.Keywords
This publication has 131 references indexed in Scilit:
- Door-to-Balloon Time and Mortality among Patients Undergoing Primary PCINew England Journal of Medicine, 2013
- Impact of cell number and microvascular obstruction in patients with bone-marrow derived cell therapy: final results from the randomized, double-blind, placebo controlled intracoronary Stem Cell therapy in patients with Acute Myocardial Infarction (SCAMI) trialClinical Research in Cardiology, 2013
- REstoration of COronary flow in patients with no-reflow after primary coronary interVEntion of acute myocaRdial infarction (RECOVER)American Heart Journal, 2012
- Impact of microvascular obstruction and infarct size on left ventricular remodeling in reperfused myocardial infarction: a contrast-enhanced cardiac magnetic resonance imaging studyThe International Journal of Cardiovascular Imaging, 2011
- 5-Year Prognostic Value of No-Reflow Phenomenon After Percutaneous Coronary Intervention in Patients With Acute Myocardial InfarctionJournal of the American College of Cardiology, 2010
- Adverse Cardiovascular Outcomes in Women With Nonobstructive Coronary Artery DiseaseArchives of Internal Medicine, 2009
- Reversible microvascular dysfunction coupled with persistent myocardial dysfunction: implications for post-infarct left ventricular remodellingHeart, 2007
- Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trialAmerican Heart Journal, 2006
- The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusionBasic Research in Cardiology, 2006
- Left ventricular remodeling after primary coronary angioplasty in patients treated with abciximab or intracoronary adenosineAmerican Heart Journal, 2005